RFK Jr. Initiates Safety Review of Abortion Pill Amid Federal Investigations

The FDA announced it will study the safety of mifepristone, an abortion pill, which could lead to new restrictions such as requiring in-person dispensing, potentially limiting access via telehealth, especially in states with abortion bans. The move has sparked controversy, with pro-choice advocates arguing it is political interference, while officials claim it is a necessary safety review.